BRPI0907563A2 - Derivados de 4,5-di-hidro-xazol-2-il amina - Google Patents
Derivados de 4,5-di-hidro-xazol-2-il aminaInfo
- Publication number
- BRPI0907563A2 BRPI0907563A2 BRPI0907563-1A BRPI0907563A BRPI0907563A2 BR PI0907563 A2 BRPI0907563 A2 BR PI0907563A2 BR PI0907563 A BRPI0907563 A BR PI0907563A BR PI0907563 A2 BRPI0907563 A2 BR PI0907563A2
- Authority
- BR
- Brazil
- Prior art keywords
- dihydroxazol
- ylamine derivatives
- ylamine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08151546 | 2008-02-18 | ||
| PCT/EP2009/051452 WO2009103626A1 (en) | 2008-02-18 | 2009-02-09 | 4, 5-dihydro-oxazol-2-yl amine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0907563A2 true BRPI0907563A2 (pt) | 2015-08-04 |
Family
ID=40545768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0907563-1A BRPI0907563A2 (pt) | 2008-02-18 | 2009-02-09 | Derivados de 4,5-di-hidro-xazol-2-il amina |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7989449B2 (pt) |
| EP (1) | EP2245019B1 (pt) |
| JP (1) | JP5258904B2 (pt) |
| KR (1) | KR101259240B1 (pt) |
| CN (1) | CN101952260B (pt) |
| AR (1) | AR070395A1 (pt) |
| AU (1) | AU2009216825A1 (pt) |
| BR (1) | BRPI0907563A2 (pt) |
| CA (1) | CA2712228C (pt) |
| CL (1) | CL2009000349A1 (pt) |
| ES (1) | ES2398017T3 (pt) |
| IL (1) | IL206765A0 (pt) |
| MX (1) | MX2010008347A (pt) |
| PE (1) | PE20091466A1 (pt) |
| TW (1) | TW200938537A (pt) |
| WO (1) | WO2009103626A1 (pt) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7763609B2 (en) * | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US7700603B2 (en) * | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| WO2006138264A2 (en) * | 2005-06-14 | 2006-12-28 | Schering Corporation | Aspartyl protease inhibitors |
| US8722708B2 (en) | 2005-06-14 | 2014-05-13 | Merck Sharp & Dohme Inc. | Substituted isoindolines as aspartyl protease inhibitors |
| ES2537898T3 (es) | 2005-10-25 | 2015-06-15 | Shionogi & Co., Ltd. | Derivados de aminotiazolidina y aminotetrahidrotiazepina como inhibidores de BACE 1 |
| CA2653650A1 (en) * | 2006-06-12 | 2007-12-21 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| EP2151435A4 (en) | 2007-04-24 | 2011-09-14 | Shionogi & Co | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
| AU2008245082B8 (en) | 2007-04-24 | 2012-09-13 | Shionogi & Co., Ltd. | Aminodihydrothiazine derivatives substituted with a cyclic group |
| AU2009239536C1 (en) * | 2008-04-22 | 2012-12-13 | Merck Sharp & Dohme Corp. | Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
| US8637504B2 (en) | 2008-06-13 | 2014-01-28 | Shionogi & Co., Ltd. | Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity |
| US8450308B2 (en) * | 2008-08-19 | 2013-05-28 | Vitae Pharmaceuticals, Inc. | Inhibitors of beta-secretase |
| MX2011002705A (es) * | 2008-09-11 | 2011-09-09 | Amgen Inc | Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso. |
| WO2010047372A1 (ja) | 2008-10-22 | 2010-04-29 | 塩野義製薬株式会社 | Bace1阻害活性を有する2-アミノピリミジン-4-オンおよび2-アミノピリジン誘導体 |
| WO2010105179A2 (en) | 2009-03-13 | 2010-09-16 | Vitae Pharmaceuticals, Inc. | Inhibitors of beta-secretase |
| US20110065695A1 (en) * | 2009-09-11 | 2011-03-17 | Jeremy Beauchamp | Use of aminodihydrothiazines for the treatment or prevention of diabetes |
| UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
| US8354441B2 (en) | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
| US20120245154A1 (en) | 2009-12-09 | 2012-09-27 | Shionogi & Co., Ltd. | Substituted aminothiazine derivative |
| UA103272C2 (uk) * | 2009-12-11 | 2013-09-25 | Ф. Хоффманн-Ля Рош Аг | 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2 |
| RU2012129168A (ru) | 2009-12-11 | 2014-01-20 | Сионоги Энд Ко. Лтд. | Производные оксазина |
| WO2011077726A1 (ja) | 2009-12-24 | 2011-06-30 | 塩野義製薬株式会社 | 4-アミノ-1,3-チアジンまたはオキサジン誘導体 |
| JP5828848B2 (ja) | 2010-02-24 | 2015-12-09 | ヴァイティー ファーマシューティカルズ,インコーポレイテッド | ベータセクレターゼインヒビター |
| MX2012010658A (es) | 2010-03-15 | 2012-12-05 | Amgen Inc | Compuestos de anillo espiro tetraciclico como moduladores de beta-secretasa. |
| US8497264B2 (en) | 2010-03-15 | 2013-07-30 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| US8815881B2 (en) * | 2010-08-09 | 2014-08-26 | Hoffmann-La Roche Inc. | 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
| CA2816285A1 (en) | 2010-10-29 | 2012-05-03 | Shionogi & Co., Ltd. | Naphthyridine derivative |
| US9018219B2 (en) | 2010-10-29 | 2015-04-28 | Shionogi & Co., Ltd. | Fused aminodihydropyrimidine derivative |
| KR101569260B1 (ko) * | 2011-01-13 | 2015-11-13 | 노파르티스 아게 | 신규 헤테로시클릭 유도체 및 신경계 장애의 치료에서의 그의 용도 |
| US8399459B2 (en) * | 2011-02-02 | 2013-03-19 | Hoffmann-La Roche Inc. | 1,4 oxazines as BACE1 and/or BACE2 inhibitors |
| US9346827B2 (en) | 2011-02-07 | 2016-05-24 | Amgen Inc. | 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use |
| WO2012147763A1 (ja) | 2011-04-26 | 2012-11-01 | 塩野義製薬株式会社 | オキサジン誘導体およびそれを含有するbace1阻害剤 |
| WO2013044092A1 (en) | 2011-09-21 | 2013-03-28 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| DE102011055815A1 (de) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung |
| TWI557112B (zh) | 2012-03-05 | 2016-11-11 | 百靈佳殷格翰國際股份有限公司 | β-分泌酶抑制劑 |
| DE102012016908A1 (de) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung |
| TW201422592A (zh) | 2012-08-27 | 2014-06-16 | Boehringer Ingelheim Int | β-分泌酶抑制劑 |
| WO2014052398A1 (en) | 2012-09-28 | 2014-04-03 | Vitae Pharmaceuticals, Inc. | Inhibitor of beta-secretase |
| JP2016501827A (ja) | 2012-10-24 | 2016-01-21 | 塩野義製薬株式会社 | Bace1阻害作用を有するジヒドロオキサジンまたはオキサゼピン誘導体 |
| US9725469B2 (en) | 2012-11-15 | 2017-08-08 | Amgen, Inc. | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| JP6568937B2 (ja) * | 2014-10-10 | 2019-08-28 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Bace1阻害剤 |
| CA2979113A1 (en) | 2015-03-20 | 2016-09-29 | F. Hoffmann-La Roche Ag | Bace1 inhibitors |
| EP3463359A4 (en) * | 2016-06-02 | 2020-08-26 | Purdue Pharma LP | TRACE AMINE RECEPTOR 1 AGONISTS AND PARTIAL PAIN AGONISTS |
| CN113729026A (zh) * | 2021-10-09 | 2021-12-03 | 合肥巨卓农业技术开发有限公司 | 一种包含啶磺草胺和异丙隆的复合除草剂 |
| TW202342013A (zh) * | 2022-02-10 | 2023-11-01 | 英屬開曼群島商百濟神州有限公司 | 雜環化合物、其組成物及用其進行治療之方法 |
| WO2024112544A1 (en) * | 2022-11-22 | 2024-05-30 | Albemarle Corporation | Liquid weighting agents for oil-based fluids |
| CN116478010B (zh) * | 2023-04-27 | 2026-08-11 | 青岛恒宁生物科技有限公司 | 一种一锅法制备间取代基苯乙酮偶联化合物的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK302185A (da) * | 1984-07-05 | 1986-01-06 | Rolland Sa A | 2-amino-oxazoliner samt fremgangsmaade til deres fremstilling |
| CA2579724A1 (en) * | 2004-06-16 | 2006-01-26 | Wyeth | Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
| TW200734311A (en) * | 2005-11-21 | 2007-09-16 | Astrazeneca Ab | New compounds |
| CN101360716A (zh) * | 2005-11-21 | 2009-02-04 | 阿斯利康(瑞典)有限公司 | 新颖的2-氨基-咪唑-4-酮化合物及其在制备用于治疗认知缺损、阿尔茨海默病、神经变性和痴呆的药物中的用途 |
| CA2675221C (en) * | 2007-02-02 | 2016-02-23 | F. Hoffmann-La Roche Ag | Novel 2-aminooxazolines as taar1 ligands |
-
2009
- 2009-02-09 CN CN2009801052316A patent/CN101952260B/zh not_active Expired - Fee Related
- 2009-02-09 JP JP2010547144A patent/JP5258904B2/ja not_active Expired - Fee Related
- 2009-02-09 EP EP09711573A patent/EP2245019B1/en not_active Not-in-force
- 2009-02-09 AU AU2009216825A patent/AU2009216825A1/en not_active Abandoned
- 2009-02-09 CA CA2712228A patent/CA2712228C/en not_active Expired - Fee Related
- 2009-02-09 MX MX2010008347A patent/MX2010008347A/es active IP Right Grant
- 2009-02-09 KR KR1020107018239A patent/KR101259240B1/ko not_active Expired - Fee Related
- 2009-02-09 BR BRPI0907563-1A patent/BRPI0907563A2/pt not_active IP Right Cessation
- 2009-02-09 WO PCT/EP2009/051452 patent/WO2009103626A1/en not_active Ceased
- 2009-02-09 ES ES09711573T patent/ES2398017T3/es active Active
- 2009-02-12 US US12/369,782 patent/US7989449B2/en not_active Expired - Fee Related
- 2009-02-16 CL CL2009000349A patent/CL2009000349A1/es unknown
- 2009-02-16 AR ARP090100540A patent/AR070395A1/es unknown
- 2009-02-16 PE PE2009000228A patent/PE20091466A1/es not_active Application Discontinuation
- 2009-02-16 TW TW098104870A patent/TW200938537A/zh unknown
-
2010
- 2010-07-01 IL IL206765A patent/IL206765A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2010008347A (es) | 2010-11-12 |
| KR101259240B1 (ko) | 2013-04-29 |
| CA2712228C (en) | 2013-04-16 |
| CL2009000349A1 (es) | 2010-02-19 |
| JP5258904B2 (ja) | 2013-08-07 |
| US20090209529A1 (en) | 2009-08-20 |
| US7989449B2 (en) | 2011-08-02 |
| IL206765A0 (en) | 2010-12-30 |
| CN101952260A (zh) | 2011-01-19 |
| EP2245019B1 (en) | 2012-11-14 |
| AU2009216825A1 (en) | 2009-08-27 |
| KR20100130595A (ko) | 2010-12-13 |
| ES2398017T3 (es) | 2013-03-13 |
| AR070395A1 (es) | 2010-03-31 |
| WO2009103626A1 (en) | 2009-08-27 |
| EP2245019A1 (en) | 2010-11-03 |
| CA2712228A1 (en) | 2009-08-27 |
| TW200938537A (en) | 2009-09-16 |
| JP2011512378A (ja) | 2011-04-21 |
| PE20091466A1 (es) | 2009-09-24 |
| CN101952260B (zh) | 2013-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE555107T1 (de) | 2-aza-bicyclo-ä2,2,1-üheptan-derivate | |
| BRPI0811718A2 (pt) | Derivados de 3,3-espiroindolinona | |
| DE602008005634D1 (de) | 1,1,1-trifluor-2-hydroxy-3-phenylpropan-derivate | |
| BRPI0813707A2 (pt) | Derivados de pirimidinil-piridazinona | |
| BRPI0820112A2 (pt) | Derivados de isoxazol-piridina | |
| BRPI0809992A2 (pt) | Derivados de pirrolopirimidina | |
| BRPI0820113A2 (pt) | Derivados de isoxazolo-piridazina | |
| BRPI0816970A2 (pt) | 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas | |
| DK2209786T3 (da) | Pyrimidinsubstituerede purinderivater | |
| BRPI0812155A2 (pt) | derivados de espiroindolinona | |
| HRP20151058T1 (xx) | Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe | |
| BRPI0817935A2 (pt) | Derivados de biarila | |
| IL206765A0 (en) | 4,5-dihydro-oxazol-2-yl-amine derivatives | |
| BRPI0813836A2 (pt) | Derivados pirazólicos | |
| BRPI0814236A2 (pt) | Derivados de quinazolinamida | |
| BRPI0812518A2 (pt) | Derivados de indazolamida | |
| BRPI0820649A2 (pt) | Derivados de isoxazalo-pirazina | |
| DK2152370T3 (da) | Aryletherpyridazinonderivater | |
| EP2344471A4 (en) | 7-PIPERIDINALKYL-3,4-dihydroquinolone DERIVATIVE | |
| BRPI0917446A2 (pt) | derivados de acilaminobenzamida. | |
| BRPI0906357A2 (pt) | Derivados de oxazepinopirimidona arilamida substituídos | |
| BRPI0916363A2 (pt) | derivados de 4,5-di-hidro-oxazol-2-ila | |
| BRPI0815059A2 (pt) | Derivado de 1,3-di-hidroisoindol | |
| BRPI0922652A2 (pt) | Derivados de quinazolinamida | |
| BRPI0913234A2 (pt) | derivados de tiazolilpiperidina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |